ARCHIVES

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Two RFAs, Changes One To PA, Kills One On Liposomes

June 10, 1988

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey.

February 16, 2001

Funding Opportunities (8-page issue).

April 18, 2003

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999

Two Groups Form to Mark Cancer Act’s 25th Anniversary

May 31, 1996